InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,718.00
(
0.20%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.82
(
0.52%
)
Bitcoin
62,783.21
(
2.17%
)
Post# of 2495
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

axelvento

Send PM Follow Ignore
Followers 51
Posts 9010
Boards Moderated 1
Alias Born 10/25/2007

axelvento

Re: None

Thursday, 11/29/2018 4:18:23 AM

Thursday, November 29, 2018 4:18:23 AM

Post# of 2495
Neutrolin® U.S.
Phase 3 Trial Stopped at Interim Review for Efficacy
FDA meeting planned Q4 2018 to agree on next steps to complete development plan.



waiting for$$$$$$$$



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CRMD News
More CRMD News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!